$1.61 Billion is the total value of Hudson Executive Capital LP's 7 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
DB | Buy | DEUTSCHE BANK A Gnamen akt | $801,182,000 | +10.2% | 67,064,476 | +0.9% | 49.73% | -5.5% |
CATM | CARDTRONICS PLC | $335,421,000 | +9.9% | 8,644,880 | 0.0% | 20.82% | -5.7% | |
USAT | Buy | USA TECHNOLOGIES INC | $140,590,000 | +21.7% | 11,995,765 | +8.8% | 8.73% | +4.4% |
EHTH | Buy | EHEALTH INC | $109,168,000 | +106.0% | 1,501,002 | +100.0% | 6.78% | +76.7% |
TVTY | TIVITY HEALTH INC | $107,031,000 | +13.9% | 4,795,310 | 0.0% | 6.64% | -2.3% | |
VRAY | Buy | VIEWRAY INC | $64,270,000 | +29.2% | 14,774,684 | +13.4% | 3.99% | +10.8% |
NTRA | Buy | NATERA INC | $53,520,000 | +42.0% | 527,086 | +39.2% | 3.32% | +21.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
DEUTSCHE BANK AG | 21 | Q3 2023 | 88.0% |
EAGLE PHARMACEUTICALS INC | 16 | Q4 2019 | 34.5% |
NATERA INC | 15 | Q4 2022 | 4.6% |
CARDTRONICS PLC | 14 | Q1 2021 | 43.3% |
VIEWRAY INC | 14 | Q2 2023 | 8.2% |
ATRICURE INC | 13 | Q3 2019 | 20.9% |
CIT GROUP INC | 11 | Q2 2018 | 26.4% |
TIVITY HEALTH INC | 11 | Q1 2022 | 12.3% |
CORINDUS VASCULAR ROBOTICS I | 11 | Q3 2019 | 9.7% |
CANTALOUPE INC | 10 | Q3 2023 | 11.8% |
View Hudson Executive Capital LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
ViewRay, Inc. | July 21, 2023 | 6,752,093 | 3.7% |
Akoya Biosciences, Inc. | February 07, 2023 | 1,892,204 | 5.0% |
Liberated Syndication Inc. | March 23, 2022 | 2,400,000 | 8.6% |
eHealth, Inc. | March 11, 2022 | 750,501 | 2.8% |
Talkspace, Inc. | November 17, 2021 | 17,980,600 | 11.2% |
USA TECHNOLOGIES INC | February 26, 2021 | 11,995,765 | 16.9% |
Cardtronics plc | December 15, 2020 | 8,644,880 | 19.4% |
TIVITY HEALTH, INC. | May 11, 2020 | 4,795,310 | 9.9% |
EAGLE PHARMACEUTICALS, INC. | January 16, 2020 | 361,897 | 2.6% |
Corindus Vascular Robotics, Inc.Sold out | October 31, 2019 | 0 | 0.0% |
View Hudson Executive Capital LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
144 | 2024-02-21 |
4 | 2024-02-21 |
SC 13D/A | 2024-02-21 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
SC 13D/A | 2023-07-21 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
SC 13D/A | 2023-02-07 |
View Hudson Executive Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.